Overview

Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study in healthy male and female volunteers will investigate the safety and tolerability of three increasing oral doses of tafamidis
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer